ArticleNPJ digital medicine2026
Lightweight liquid neural networks decipher salivary metabolic fingerprinting for high-risk periodontitis screening in diabetes.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Type 2 diabetes (T2DM) and periodontitis are bidirectionally linked diseases that both involve chronic inflammation; their co‑occurrence represents a high‑risk clinical condition requiring timely identification. In this proof‑of‑concept, dual‑center feasibility study (n = 426), we evaluate a rapid, non‑invasive approach for identifying individuals with co‑occurring periodontitis and T2DM by integrating salivary metabolic fingerprints acquired by probe electrospray ionization mass spectrometry (PESI‑MS, ~0.7 min per sample) with demographic covariates (age and sex) as inputs for a lightweight liquid neural network (LNN) classifier. A total of 426 participants (H: healthy controls, n = 114; P: periodontitis, n = 209; MP: periodontitis with T2DM, n = 103) were enrolled, and the data were randomly split into training (80%) and test (20%) sets. We benchmarked the LNN against conventional classifiers (PLS‑DA, random forest, SVM) and other deep‑learning models (BiLSTM, MHA‑LSTM). While conventional models showed limited performance (AUC 0.73-0.78), deep‑learning models, which leverage the sequential structure of m/z‑ordered spectral data, achieved substantially higher accuracy. Notably, the LNN achieved the highest test accuracy (91.9%) with 100% recall for the MP group, while requiring approximately one‑third the trainable parameters of other recurrent networks. This study demonstrates the feasibility of combining PESI‑MS metabolic fingerprinting with efficient deep learning for high‑risk periodontitis screening.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.